DK0762895T3 - Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus - Google Patents

Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus

Info

Publication number
DK0762895T3
DK0762895T3 DK95917797T DK95917797T DK0762895T3 DK 0762895 T3 DK0762895 T3 DK 0762895T3 DK 95917797 T DK95917797 T DK 95917797T DK 95917797 T DK95917797 T DK 95917797T DK 0762895 T3 DK0762895 T3 DK 0762895T3
Authority
DK
Denmark
Prior art keywords
protection against
immunodeficiency virus
virus infection
human immunodeficiency
against human
Prior art date
Application number
DK95917797T
Other languages
Danish (da)
English (en)
Inventor
Barton F Haynes
Thomas J Palker
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of DK0762895T3 publication Critical patent/DK0762895T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK95917797T 1994-04-29 1995-04-28 Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus DK0762895T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23530594A 1994-04-29 1994-04-29
PCT/US1995/005465 WO1995029700A1 (fr) 1994-04-29 1995-04-28 Vaccin de synthese protegeant contre l'infection par le vih

Publications (1)

Publication Number Publication Date
DK0762895T3 true DK0762895T3 (da) 2002-09-02

Family

ID=22884945

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95917797T DK0762895T3 (da) 1994-04-29 1995-04-28 Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus

Country Status (10)

Country Link
EP (1) EP0762895B1 (fr)
JP (1) JPH09512561A (fr)
AT (1) ATE221786T1 (fr)
AU (1) AU707894B2 (fr)
CA (1) CA2189045A1 (fr)
DE (1) DE69527708T2 (fr)
DK (1) DK0762895T3 (fr)
ES (1) ES2177648T3 (fr)
PT (1) PT762895E (fr)
WO (1) WO1995029700A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7465696A (en) * 1995-10-20 1997-05-07 Duke University Synthetic vaccine for protection against human immunodeficiency virus infection
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
NZ515322A (en) * 1999-05-13 2004-03-26 Wyeth Corp Adjuvant combination formulations
JP2004503205A (ja) 2000-02-04 2004-02-05 デューク・ユニバーシティー ヒト免疫不全ウイルスワクチン
JP2004511444A (ja) 2000-09-22 2004-04-15 デューク・ユニバーシティー 免疫原
US7033593B2 (en) 2000-09-22 2006-04-25 Duke University Immunogen comprising an HIV envelope protein, a ligand and H2 peptide
EP1411770A4 (fr) 2001-07-05 2006-05-10 Chiron Corp Polynucleotides codant des polypeptides de type c du vih antigeniques, polypeptides et leurs utilisations
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
WO2003039470A2 (fr) 2001-11-07 2003-05-15 Duke University Immunogene polyvalent
US7195768B2 (en) 2001-11-07 2007-03-27 Duke University Polyvalent immunogen
US7172761B2 (en) 2001-11-07 2007-02-06 Duke University Polyvalent immunogen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013548A (en) * 1987-09-08 1991-05-07 Duke University Production of antibodies to HIV
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV

Also Published As

Publication number Publication date
PT762895E (pt) 2002-11-29
WO1995029700A1 (fr) 1995-11-09
DE69527708D1 (de) 2002-09-12
ES2177648T3 (es) 2002-12-16
AU2372695A (en) 1995-11-29
ATE221786T1 (de) 2002-08-15
EP0762895B1 (fr) 2002-08-07
JPH09512561A (ja) 1997-12-16
AU707894B2 (en) 1999-07-22
DE69527708T2 (de) 2003-04-30
EP0762895A1 (fr) 1997-03-19
EP0762895A4 (fr) 1997-08-27
CA2189045A1 (fr) 1995-11-09

Similar Documents

Publication Publication Date Title
DK0762895T3 (da) Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus
EE9900343A (et) Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
IL91007A0 (en) Synthetic vaccine against aids virus
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
RU94042722A (ru) Химерный белок, ген, клетка, вектор, способ получения химерного белка, вакцина
KR890701127A (ko) 비루스 글리코 단백질 서브유니트 백신을 사용한 비루스 감염에 대한 비강내 면역화방법
ATE154610T1 (de) Synthetische vom hiv-gp120-env-protein abgeleitete peptide und ihre anwendung
FI913476A7 (fi) Konjugaattirokotteita, jotka sisältävät immunogeenista proteiinia, HIV-tyyppisiä peptidejä ja anionisia ryhmiä
EP0225066A3 (fr) Antigènes de structure peptidique et leur procédé de préparation
DK0661999T3 (da) Vacciner mod felint immundefekt virus (FIV)
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
CY1105010T1 (el) Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου
DE68925660D1 (de) Peptidfragmente von HIV
KR920004422A (ko) Hiv의 주요 중화 결정인자
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
CO5300406A1 (es) Vacuna
CA2100591A1 (fr) Vaccin antirabique avirulent
WO1993014206A3 (fr) Peptides synthetiques destines a un vaccin contre la rubeole
FR2769916B1 (fr) Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
EP0270295A3 (fr) Vaccin conjugué
KR910011897A (ko) 말라리아 백신
ATE247485T1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
CY1105176T1 (el) Χιμαιρικα νουκλεϊνικα οξεα και πολυπεπτιδια του ιου της λυσσας
DE60022995D1 (de) Impfstoff
RU97107302A (ru) Способ иммунизации против инфекции, вызываемой вирусом клещевого энцефалита